In The News

Cross-Practice Attorneys Examine What Self-Disclosure Guidance Means for Federal Research Awardees

Practices: Health Care, Life Sciences, Clinical Research, FDA Regulatory, Data, Privacy & Cybersecurity, Health Privacy & Security, Regulatory Enforcement & Civil Litigation

Capital Insights.

In a Law360 article published on August 8, health care and life sciences counsel Valerie Bonham (Washington, D.C.), litigation & enforcement partner Kirsten Mayer (Boston), and health care partner Mark Barnes (Boston) examined what the self-disclosure guidance issued by the Office of the Inspector General of the U.S. Department of Health and Human Services means for federal research grantees including universities, academic medical centers and corporations.

The co-authors discuss the benefits, risks and best practices of federal research grantee voluntary disclosure and examine the OIG guidance and checklist for making a self-disclosure.

Cookie Settings